| Bioactivity | Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
| Name | Eptinezumab |
| CAS | 1644539-04-7 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739. |